Delivery Order SPE2DB22D9207-SPE2DB24FH5FP

Award Date 9/4/24
Potential Completion Date 9/25/24
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,461.66, is a firm fixed-price delivery order for the supply of EXPAREL 266 MG/20 ML VIAL 20ML. The contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at up to $1,148.40, is a firm fixed-price delivery order for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program....
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,461.66 firm fixed-price delivery order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order valued at $4,974.44 for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,404.94 firm fixed-price delivery order is for the supply of EXPAREL 1.3% 20ML 10S, a specialty pharmaceutical product. The contract has no set-aside designation and is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the agency to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $24,182.60 and is a firm fixed-price delivery order with no set-aside designation. The contract covers the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. DMS...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $14,923.32 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a wide range of pharmaceutical items to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $30,360.90 firm fixed-price delivery order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,660.16 firm fixed-price delivery order is for the provision of EXPAREL 266 MG/20 ML VIAL 20ML, a specialized pharmaceutical product. This award is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which enables the agency to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,510.63, is a firm fixed-price delivery order for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
  • SPE2DB22D9207
    Indefinite Delivery Contract
  • SPE2DB22D9207-SPE2DB24FH5FP
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,461.66, is a firm fixed-price delivery order for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product.

The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Through this contract and the broader IDC, DMS Pharmaceutical Group provides both routine and critical medications, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. This contract and the company's position as a prime vendor for pharmaceutical products and services solidify DMS Pharmaceutical Group's role as a crucial supplier in the federal pharmaceutical supply chain.

Generated 12/4/24, 9:47 AM